InGeNA actively consults with our members to ensure their voices are represented in major submissions to government and other agencies on genomics and precision medicine.

As a united voice for industry, we advocate for policies that support innovation and patient outcomes.

Listed below are our most recent submissions.

InGeNA’s submission to the draft National Health Genomics Policy Framework (2026–2030) represents a united industry response developed through the Genomics Industry Roundtable, member feedback, and collaboration with partners and the Consumer Advisory Group. This joint effort calls for clearer national targets, measurable outcomes, and funding mechanisms to ensure the Framework drives meaningful and timely integration of genomics into routine clinical care.